Correlation Between MAIA Biotechnology and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Enlivex Therapeutics, you can compare the effects of market volatilities on MAIA Biotechnology and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Enlivex Therapeutics.

Diversification Opportunities for MAIA Biotechnology and Enlivex Therapeutics

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between MAIA and Enlivex is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between MAIA Biotechnology and Enlivex Therapeutics

Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 1.68 times more return on investment than Enlivex Therapeutics. However, MAIA Biotechnology is 1.68 times more volatile than Enlivex Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.7 per unit of risk. If you would invest  266.00  in MAIA Biotechnology on August 24, 2024 and sell it today you would lose (51.00) from holding MAIA Biotechnology or give up 19.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MAIA Biotechnology  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

MAIA Biotechnology and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MAIA Biotechnology and Enlivex Therapeutics

The main advantage of trading using opposite MAIA Biotechnology and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind MAIA Biotechnology and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume